Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Home - The Pharma Times | Pharma & Health Care News Portal
Saturday, April 27, 2024

Biotechnology

Intuitive and Max Healthcare to launch Southeast Asia’s first Total Program Observation Centre for...

Mumbai, August 24 , 2023: Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, and Max Healthcare, one...

DEP’s innovative solution MeshWorks 2020 is set to revolutionize the Bio-Medical Industry

MeshWorks 2020 will make product development in the healthcare industry more efficient and productive Chennai, May 14, 2020: DEP MeshWorks 2020, a CAE driven engineering platform, for...

IT & Software Support

Appointments

Awards

Cross-industry Green Faith Environmental Protection Practice of Taiwan Excellence Award-Winning Companies

Mumbai, August 26, 2020: Environmental protection is a common international issue, and it is also the endeavor of many large global companies. In recent...

Financial Results

Approvals

Clinical Trails

Phase III DECISION Trial of Nexavar® (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival...

Berlin, January 3, 2013 – Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that a Phase III trial of Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer has met its primary endpoint of a statistically significant improvement in progression-free survival. The study, called DECISION, evaluated the efficacy and safety of Nexavar compared to placebo. The safety and tolerability were generally consistent with the known profile of Nexavar. Detailed efficacy and safety analysis from this study are expected to be presented at an upcoming medical meeting. Effective treatment options are urgently needed for patients with RAI-refractory differentiated thyroid cancer,” said Dimitris Voliotis, MD, Vice President, Global Clinical Development Oncology, Bayer HealthCare. “We are pleased that the results of this study demonstrate that Nexavar may provide a treatment option for these patients.

Bulk Drug

Health Care

Alternative Medicine

Eye Care

Clear vision restored in youth suffering from rare eye disorder with bulging, conical-shaped cornea

Mumbai, October 11, 2023 :  Tushar Salunke, a 27-year-old HR professional hailing from Palghar, found himself facing an unexpected challenge when diagnosed with keratoconus,...

Sharp Spike in Cases of Mature Cataract and Dry Eyes during Pandemic

Bengaluru, February 23, 2021: The ongoing pandemic has led to increased severity and morbidity in eye conditions of people in Bengaluru because of delayed...

Product News

Media Partners

Spotlight

Investments

Packaging

Latest News

Liver Cancer Awareness: The Importance of Early Diagnosis and Screening

 Dr. Shantling Nigudgi Sr. Consultant Radiation Oncology, HCG Cancer Centre, Kalaburagi.  Liver cancer is one of the rare cancer. The most common form of Liver...

Medanta’s COVID Safe Commitment to Patients

End-to-End Services, World-Class Safety Benchmarks  Gurugram, May 19, 2020:  In continuation of delivering world-class healthcare, during the COVID-19 pandemic,Medanta (https://www.medanta.org/)has reinforced its stringent, internationally benchmarked...

JSW Group commits over INR 100 Crores to PM-CARES Fund and aid for other...

Mumbai, March 30, 2020 :  In light of the current COVID -19 Crisis, the JSW Group has committed INR 100 Crores to the Prime Minister’s Citizen Assistance and Relief...

Dental Care

The Global Dental and Diagnostics Surgical Equipment Market on The Rise

New Delhi, February 16, 2022: As of recent research, it has been predicted that the global dental and diagnostics surgical instrument industry is all...

Hospital Management

HCG Cancer Hospital completes Comprehensive Genomic Profi­ling (CGP) of 1000+ Cancer Patients

Bengaluru , August 22, 2023: Envisioned to drive a new standard of cancer care, Triesta Sciences, a Unit of HealthCare Global Enterprises Limited (HCG Cancer...

Common Symptoms of Gallbladder Cancer: Recognizing the Signs

By Dr Satya Srinivas A, Consultant - Medical Oncologist, HCG Cancer Centre, Vijaywada One of the most rare but serious forms of cancer is Gallbladder cancer...

Drug Discovery & Development

North America to Dominate Drug Delivery Devices Market During Forecast Period – TechSci Research

Rising prevalence of chronic diseases is expected to drive the growth of global drug delivery devices market New Delhi, July 20, 2020: According to TechSci...

Suppliers

Technology

Impact Biomedical’s Majority Owned Next Generation Medical Technologies Valued at USD...

Singapore, April 28, 2020 : (ACN Newswire) - SGX-listed Singapore eDevelopment Ltd's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc., announced recently that their...

Companies

Akshay Kumar launches GOQii Vital ECG, to monitor your heart health...

- Bollywood Superstar Akshay Kumar launched the ECG device today on GOQii Play, one of the leading mobile OTT platforms for health & fitness -...

Marketing

Our Partners

Machinery & Equipments